Centiva Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Centiva Capital’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-79,500	Closed	-$1.9M	–	1940
2021 Q1	$1.9M	Buy	+79,500	New	+$1.48M	0.07%	202

Centiva Capital's GNMK Position: Q2 2021 in Review

Centiva Capital sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 79,500 shares — an estimated $1.9M sold.

Centiva Capital first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $1.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Centiva Capital reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Centiva Capital sold 79,500 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.9M.
Centiva Capital first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Centiva Capital's GenMark Diagnostics, Inc position peaked at $1.9M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Centiva Capital's 13F filing for Q2 2021, filed 16 Aug 2021.